HealthVerity Marketplace adds Premier, Inc. data to support evidence generation across the product lifecycle

Premier, Inc.’s inpatient and outpatient data is now accessible through the HealthVerity Marketplace, offering expanded real-world evidence (RWE) capabilities to support decision-making across clinical development, market access, and post-approval research.

HealthVerity has announced the integration of Premier, Inc.’s data assets into its HealthVerity Marketplace™, expanding the platform’s real-world data (RWD) offering for life sciences organizations. The integration includes access to Premier’s inpatient and outpatient electronic medical records (EMRs), chargemaster data, and laboratory results, enabling more detailed and longitudinal analyses across a range of clinical and commercial use cases.

The HealthVerity Marketplace is one of the largest verified ecosystems of de-identified healthcare and consumer data in the US, offering HIPAA-compliant linkage across more than 340 million individuals. The addition of Premier’s data is expected to support evidence generation in areas such as clinical development, market access, safety monitoring, and epidemiological research.

Premier’s data assets include the Premier® Healthcare Database (PHD), which has been used for nearly 25 years by researchers across industry, academia, and government. The PHD includes the largest US chargemaster database and supports the analysis of healthcare utilization, outcomes, and cost. Premier also provides EMR chart retrieval and review services, which may be used in regulatory-grade research and validation.

“Having the right data is critical for life sciences organizations aspiring to create meaningful change in healthcare,” explained Denise Juliano, Group Vice President, Premier Applied Sciences. “Premier's partnership with HealthVerity securely links Premier data with other real-world datasets, expanding on its longitudinal view of the patient journey that helps measure the effectiveness, quality and cost of therapies.”

Andrew Kress, CEO of HealthVerity, commented: “Premier's extensive, high-quality data adds substantial value for pharmaceutical manufacturers and healthcare innovators. These precise clinical insights are essential for therapeutic advancements and targeted patient care strategies.”